Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28018
Title: Why the renin-angiotensin-aldosterone system (RAAS) in critically ill patients can no longer be ignored.
Austin Authors: Zarbock, Alexander;Chawla, Lakhmir;Bellomo, Rinaldo 
Affiliation: Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Albert-Schweitzer-Campus 1, Geb. A1, 48149, Munster, Germany
Veterans Affairs Medical Center, San Diego, CA, USA
Department of Critical Care, The University of Melbourne, Melbourne, Australia
Department of Intensive Care, Royal Melbourne Hospital, Parkville, VIC, Australia
Intensive Care
Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
Issue Date: 14-Nov-2021
Date: 2021
Publication information: Critical Care 2021; 25(1): 389
URI: https://ahro.austin.org.au/austinjspui/handle/1/28018
DOI: 10.1186/s13054-021-03816-x
ORCID: 0000-0002-6011-8049
Journal: Critical Care
PubMed URL: 34775967
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/34775967/
Type: Journal Article
Subjects: renin-angiotensin-aldosterone
Appears in Collections:Journal articles

Show full item record

Page view(s)

10
checked on Nov 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.